Validation of the Turkish Version of the Modified Early Obstetric Warning Systems (MEOWS) Charts
1 other identifier
observational
350
1 country
1
Brief Summary
It was aimed to study MEOWS on patients in the obstetrics clinic and to evaluate the performance of this scale as a screening tool and to contribute to its usability in Turkey by translating MEOWS into Turkish.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2022
CompletedFirst Submitted
Initial submission to the registry
December 14, 2022
CompletedFirst Posted
Study publicly available on registry
January 10, 2023
CompletedJanuary 10, 2023
December 1, 2022
6 months
December 14, 2022
December 22, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Validation of the Modified Early Obstetric Warning System
Demonstrating the reliability and validity of the Modified Early Obstetric Warning System chart in Turkish. MEOWS chart is contained within a booklet and is commenced on admission to hospital. The same booklet is used during subsequent admissions to hospital during the relevant pregnant and postnatal period. Specific maternal observations that are recorded on the MEOWS chart are diastolic blood pressure, severity of pain, antenatal discharge and/or postnatal lochia and proteinurea. Physiological parameters which deviate from the norm are allocated a score. The score increases as deviation from the norm escalates. The final score then falls into one of three categories: a low, medium, or high score. A low score is 1-4, a medium score is 5-6 and a high score is 7 or more. Any single score of 3 indicates an extreme variation from the normal, which is considered at least a medium score. The colour prompts are green for a low score, amber for medium and red for high scores.
Obstetric patients older than 28 weeks of gestation and between 6 weeks postpartum
Modified Early Obstetric Warning System Chart
Calculation of sensitivity, specificity, positive and negative predictive value of the chart
At the end of the study, assessed up to 1 month.
Study Arms (1)
Pregnant and postpartum patients
Pregnant patients older than 28th gestational week and patients up to postpartum 6th week who were hospitalized in the obstetrics department
Interventions
patient-administered questionnaires (MEOWS): Obstetric early warning systems are recommended to provide timely recognition, treatment and early referral of critically ill or developing patients. The development of early warning systems from simple bedside observation charts arose from the knowledge that physiological disturbances precede critical illness. Thanks to these charts, the fact that the patient's findings are in the risky value ranges allows the clinician to evaluate the patient earlier and in detail. MEOWS is a simple screening tool for maternal morbidity.
Eligibility Criteria
Patients whose pregnancy is older than 28 weeks and between 6 weeks postpartum
You may qualify if:
- Obstetric patients receiving inpatient treatment in obstetrics and gynecology clinics
- Patients whose pregnancy is older than 28 weeks and between 6 weeks postpartum
- Patients who agreed to participate in the study
You may not qualify if:
- Patients who did not agree to participate in the study
- Patients under the age of 18
- Outpatients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Samsun Research and Education Hospital
Samsun, 55090, Turkey (Türkiye)
Related Publications (4)
Singh S, McGlennan A, England A, Simons R. A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS). Anaesthesia. 2012 Jan;67(1):12-18. doi: 10.1111/j.1365-2044.2011.06896.x. Epub 2011 Nov 9.
PMID: 22066604RESULTMoore J, Thomson D, Pimentil I, Fekad B, Graham W. Introduction of a modified obstetric early warning system -(-MOEWS-)- at an Ethiopian referral hospital: a feasibility assessment. BMJ Open Qual. 2019 Mar 30;8(1):e000503. doi: 10.1136/bmjoq-2018-000503. eCollection 2019.
PMID: 31206042RESULTTuyishime E, Ingabire H, Mvukiyehe JP, Durieux M, Twagirumugabe T. Implementing the Risk Identification (RI) and Modified Early Obstetric Warning Signs (MEOWS) tool in district hospitals in Rwanda: a cross-sectional study. BMC Pregnancy Childbirth. 2020 Sep 29;20(1):568. doi: 10.1186/s12884-020-03187-1.
PMID: 32993541RESULTSingh A, Guleria K, Vaid NB, Jain S. Evaluation of maternal early obstetric warning system (MEOWS chart) as a predictor of obstetric morbidity: a prospective observational study. Eur J Obstet Gynecol Reprod Biol. 2016 Dec;207:11-17. doi: 10.1016/j.ejogrb.2016.09.014. Epub 2016 Oct 8.
PMID: 27792988RESULT
Study Officials
- STUDY DIRECTOR
HALE KEFELI CELIK, MD
Samsun Research and Education Hospital
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Anesthesiologist, Principal Investigator
Study Record Dates
First Submitted
December 14, 2022
First Posted
January 10, 2023
Study Start
April 1, 2022
Primary Completion
October 1, 2022
Study Completion
November 1, 2022
Last Updated
January 10, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share
Our data and statistical analysis of each investigated all parameter and data are available after the publication of the clinical study